Procter & Gamble’s CFO says pricing power isn’t a given anymore—here’s how the company plans to earn it

Procter & Gamble reported Q3 net sales of $21.2 billion, up 7% year over year and above the roughly $20.5 billion consensus, while adjusted EPS of $1.59 also beat estimates of $1.56. Organic sales rose more than 3%, but management flagged a roughly $0.25-per-share FY headwind from tariffs, commodities and investments, plus a potential $150 million after-tax Q4 hit from higher oil prices tied to Middle East conflict. P&G is leaning on product innovation, such as Tide’s biggest formula upgrade in 25 years, to preserve pricing power as consumers become more price sensitive.

Analysis

The important signal is not that PG can still raise prices; it’s that the market is shifting from brand-led pass-through to product-led pass-through. That typically widens dispersion inside staples: names with genuine innovation cadence and strong retailer execution can defend gross margin, while “me-too” portfolios become trapped between private label and value-tier national brands. The second-order effect is that retailers likely gain leverage over the next 2-4 quarters as consumers compare more aggressively and shift basket composition faster than legacy consumer models assume.

The cost side is becoming more convex, not linear. Tariff and commodity pressure matters today, but the larger issue is that energy-linked inputs create delayed earnings risk: if oil remains elevated into FY27, the margin hit becomes structurally embedded rather than a one-off quarterly headwind. That favors companies with faster SKU rationalization, stronger mix, and lower promo dependence; it hurts highly leveraged consumer names that need broad-based pricing to offset inflation.

Consensus is probably underestimating how this changes competitive dynamics in cleaning, baby, and personal care. If consumers only pay up for perceived performance gains, smaller brands with one sharp benefit claim can take share from large incumbents that rely on portfolio breadth. On the other side, PG’s willingness to hold price on a major franchise suggests management is trying to preserve unit velocity first and monetize later, which is usually a healthier medium-term setup than chasing price at the expense of volume.

The tradeable edge is relative, not directional: this is a stock-selection tape within staples rather than a sector-wide bearish call. Expect the market to reward the few names that can prove innovation-led elasticity over the next earnings cycle and punish those that need repeated shelf-price increases to hold guidance. The risk to the thesis is a faster-than-expected easing in input costs, which would re-open the old pricing model and force shorts to cover.

Key Decisions for Investors

• Long PG / short a lower-quality staples basket over the next 1-2 quarters: PG has shown it can defend volume with innovation; fund the long with a short in a more price-sensitive competitor or private-label-vulnerable consumer name. Target 8-12% relative outperformance if unit elasticity holds.
• Buy PG on pullbacks around earnings support, but size as a quality compounder rather than a margin-expansion story. Upside is limited in the near term, but downside is cushioned if management continues to trade price for mix and volume.
• Short the most cost-pressured consumer brands that rely on repeated pricing to offset input inflation, especially where volume trends are already weak. Use a 3-6 month horizon; the catalyst is the next guidance reset if energy and tariffs remain sticky.
• Consider a call spread on PG for the next 6-9 months if the market is still discounting the innovation mix shift. Risk/reward improves if management can show that formula upgrades sustain mid-single-digit organic growth without additional pricing.